<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7214343\results\search\disease\results.xml">
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="transplantation is considered the ultimate solution for patients with end-stage" exact="chronic" post="liver disease or acute liver failure. Patients with liver"/>
  <result pre="is considered the ultimate solution for patients with end-stage chronic" exact="liver disease" post="or acute liver failure. Patients with liver transplant need"/>
  <result pre="considered the ultimate solution for patients with end-stage chronic liver" exact="disease" post="or acute liver failure. Patients with liver transplant need"/>
  <result pre="ultimate solution for patients with end-stage chronic liver disease or" exact="acute" post="liver failure. Patients with liver transplant need special care"/>
  <result pre="solution for patients with end-stage chronic liver disease or acute" exact="liver failure." post="Patients with liver transplant need special care starting from"/>
  <result pre="state of immune suppression could predispose to different types of" exact="infections" post="in liver transplant recipients. Currently, the world is suffering"/>
  <result pre="a new strain of the coronavirus family called COVID-19. Certain" exact="infection" post="control precautions are needed to protect immunocompromised and vulnerable"/>
  <result pre="separate outpatient clinics, and in-patient wards can prevent transmission of" exact="infection" post="both to patients and healthcare workers. Telemedicine can help"/>
  <result pre="to summarize available evidence about different aspects of the management" exact="of liver" post="transplant candidates and recipients in the era of COVID-19."/>
  <result pre="The 2019â€&quot;20 coronavirus outbreak is an ongoing pandemic of coronavirus" exact="disease" post="2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus"/>
  <result pre="ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. The outbreak was"/>
  <result pre="pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) [1]. The outbreak was identified"/>
  <result pre="of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) [1]. The outbreak was identified in"/>
  <result pre="indication for LTX, although it is now being replaced by" exact="alcoholic liver disease," post="non-alcoholic liver disease (NAFLD), and hepatocellular carcinoma (HCC), while"/>
  <result pre="for LTX, although it is now being replaced by alcoholic" exact="liver disease," post="non-alcoholic liver disease (NAFLD), and hepatocellular carcinoma (HCC), while"/>
  <result pre="it is now being replaced by alcoholic liver disease, non-alcoholic" exact="liver disease" post="(NAFLD), and hepatocellular carcinoma (HCC), while in Asia; hepatitis"/>
  <result pre="is now being replaced by alcoholic liver disease, non-alcoholic liver" exact="disease" post="(NAFLD), and hepatocellular carcinoma (HCC), while in Asia; hepatitis"/>
  <result pre="replaced by alcoholic liver disease, non-alcoholic liver disease (NAFLD), and" exact="hepatocellular carcinoma" post="(HCC), while in Asia; hepatitis B and HCC remain"/>
  <result pre="by alcoholic liver disease, non-alcoholic liver disease (NAFLD), and hepatocellular" exact="carcinoma" post="(HCC), while in Asia; hepatitis B and HCC remain"/>
  <result pre="liver disease (NAFLD), and hepatocellular carcinoma (HCC), while in Asia;" exact="hepatitis" post="B and HCC remain a common indication for LTX"/>
  <result pre="observations for SARS and other related viruses, a theoretical risk" exact="of liver" post="damage exists with COVID-19 infection [9], [10]. However, available"/>
  <result pre="viruses, a theoretical risk of liver damage exists with COVID-19" exact="infection" post="[9], [10]. However, available data only reported hepatic dysfunction"/>
  <result pre="only reported hepatic dysfunction in the form of abnormal levels" exact="of liver" post="aminotransferases and slightly elevated bilirubin levels, mainly in critically"/>
  <result pre="winter 2017/2018 showed increased organ failure scores of patients with" exact="liver cirrhosis" post="where 5 out of 11 patients with liver cirrhosis"/>
  <result pre="2017/2018 showed increased organ failure scores of patients with liver" exact="cirrhosis" post="where 5 out of 11 patients with liver cirrhosis"/>
  <result pre="with liver cirrhosis where 5 out of 11 patients with" exact="liver cirrhosis" post="developed acute liver failure during influenza infection [12]. No"/>
  <result pre="liver cirrhosis where 5 out of 11 patients with liver" exact="cirrhosis" post="developed acute liver failure during influenza infection [12]. No"/>
  <result pre="where 5 out of 11 patients with liver cirrhosis developed" exact="acute" post="liver failure during influenza infection [12]. No data available"/>
  <result pre="5 out of 11 patients with liver cirrhosis developed acute" exact="liver failure" post="during influenza infection [12]. No data available on the"/>
  <result pre="patients with liver cirrhosis developed acute liver failure during influenza" exact="infection" post="[12]. No data available on the impact of COVID-19"/>
  <result pre="No data available on the impact of COVID-19 on decompensated" exact="liver disease" post="patients awaiting LTX, but because of the known immunocompromised"/>
  <result pre="data available on the impact of COVID-19 on decompensated liver" exact="disease" post="patients awaiting LTX, but because of the known immunocompromised"/>
  <result pre="COVID-19 patients &amp;amp; health resources are being rapidly consumed, the" exact="American" post="Association for the Study of Liver Diseases (AASLD), recommended"/>
  <result pre="being rapidly consumed, the American Association for the Study of" exact="Liver Diseases" post="(AASLD), recommended against postponing transplantation. Moreover, they advised each"/>
  <result pre="rapidly consumed, the American Association for the Study of Liver" exact="Diseases" post="(AASLD), recommended against postponing transplantation. Moreover, they advised each"/>
  <result pre="candidates is another problem that may face clinicians due to" exact="limited" post="resources during the pandemic, as well as the exclusion"/>
  <result pre="workers [13]. This could emphasize the crucial role of implementing" exact="infection" post="control measures to avoid losing candidates on the LTX"/>
  <result pre="International societies like World Health Organization (WHO) and Centre for" exact="Disease" post="Control and Prevention (CDC) are always confirming the necessity"/>
  <result pre="major concern due to the fear of the possibility of" exact="disease" post="transmission. Further restrictions to prevent other routes of infections"/>
  <result pre="of disease transmission. Further restrictions to prevent other routes of" exact="infections" post="like feco-oral transmission, included colorectal surgeries and colonoscopies. Currently,"/>
  <result pre="as they would consume PPE tools which are currently running" exact="short" post="supply worldwide. The second reason that such elective procedures"/>
  <result pre="elective procedures are postponed or canceled is to prevent unnecessary" exact="infections" post="to medical staff and caregivers, which may be transmitted"/>
  <result pre="physical examination and temperature measurement along with the revision of" exact="chest" post="imaging like a computed tomography scan or a chest"/>
  <result pre="of chest imaging like a computed tomography scan or a" exact="chest" post="radiograph, and if COVID-19 is suspected or confirmed, all"/>
  <result pre="all non-emergency procedures would be delayed or canceled [18]. Indications" exact="of liver" post="transplantations in COVID-19 era Because of the rapidly changing"/>
  <result pre="COVID-19 era Because of the rapidly changing situation of COVID-19" exact="infection" post="worldwide, indications of LTX will need to be updated"/>
  <result pre="both deceased donors and living donors. The risk of donor-derived" exact="infection" post="would depend upon donor exposure, infectivity in the incubation"/>
  <result pre="major types of indications for LTX in the United States:" exact="Acute" post="liver failure, complicated cirrhosis, metabolic liver diseases, and systemic"/>
  <result pre="types of indications for LTX in the United States: Acute" exact="liver failure," post="complicated cirrhosis, metabolic liver diseases, and systemic complications of"/>
  <result pre="States: Acute liver failure, complicated cirrhosis, metabolic liver diseases, and" exact="systemic" post="complications of chronic liver disease [19]. Acute liver failure"/>
  <result pre="failure, complicated cirrhosis, metabolic liver diseases, and systemic complications of" exact="chronic" post="liver disease [19]. Acute liver failure is the most"/>
  <result pre="complicated cirrhosis, metabolic liver diseases, and systemic complications of chronic" exact="liver disease" post="[19]. Acute liver failure is the most important indication"/>
  <result pre="cirrhosis, metabolic liver diseases, and systemic complications of chronic liver" exact="disease" post="[19]. Acute liver failure is the most important indication"/>
  <result pre="liver diseases, and systemic complications of chronic liver disease [19]." exact="Acute" post="liver failure is the most important indication for emergency"/>
  <result pre="diseases, and systemic complications of chronic liver disease [19]. Acute" exact="liver failure" post="is the most important indication for emergency LTX. Common"/>
  <result pre="the most important indication for emergency LTX. Common causes of" exact="acute" post="liver failure include acetaminophen overdose, acute viral hepatitis, drug-induced"/>
  <result pre="most important indication for emergency LTX. Common causes of acute" exact="liver failure" post="include acetaminophen overdose, acute viral hepatitis, drug-induced liver injury,"/>
  <result pre="LTX. Common causes of acute liver failure include acetaminophen overdose," exact="acute" post="viral hepatitis, drug-induced liver injury, mushroom poisoning, autoimmune hepatitis,"/>
  <result pre="Common causes of acute liver failure include acetaminophen overdose, acute" exact="viral hepatitis," post="drug-induced liver injury, mushroom poisoning, autoimmune hepatitis, Wilson's disease,"/>
  <result pre="acetaminophen overdose, acute viral hepatitis, drug-induced liver injury, mushroom poisoning," exact="autoimmune hepatitis," post="Wilson's disease, acute ischemic hepatitis (shock liver), and acute"/>
  <result pre="acute viral hepatitis, drug-induced liver injury, mushroom poisoning, autoimmune hepatitis," exact="Wilson's disease," post="acute ischemic hepatitis (shock liver), and acute fatty liver"/>
  <result pre="hepatitis, drug-induced liver injury, mushroom poisoning, autoimmune hepatitis, Wilson's disease," exact="acute" post="ischemic hepatitis (shock liver), and acute fatty liver of"/>
  <result pre="liver injury, mushroom poisoning, autoimmune hepatitis, Wilson's disease, acute ischemic" exact="hepatitis" post="(shock liver), and acute fatty liver of pregnancy [19],"/>
  <result pre="autoimmune hepatitis, Wilson's disease, acute ischemic hepatitis (shock liver), and" exact="acute" post="fatty liver of pregnancy [19], [20], [21], [22]. Similarly,"/>
  <result pre="hepatitis, Wilson's disease, acute ischemic hepatitis (shock liver), and acute" exact="fatty liver" post="of pregnancy [19], [20], [21], [22]. Similarly, patients with"/>
  <result pre="liver of pregnancy [19], [20], [21], [22]. Similarly, patients with" exact="cirrhosis" post="and type 1 hepatorenal syndrome have a median survival"/>
  <result pre="pregnancy [19], [20], [21], [22]. Similarly, patients with cirrhosis and" exact="type 1" post="hepatorenal syndrome have a median survival of fewer than"/>
  <result pre="[20], [21], [22]. Similarly, patients with cirrhosis and type 1" exact="hepatorenal syndrome" post="have a median survival of fewer than two weeks"/>
  <result pre="[21], [22]. Similarly, patients with cirrhosis and type 1 hepatorenal" exact="syndrome" post="have a median survival of fewer than two weeks"/>
  <result pre="decompensation [19], [23]. Elective LTX is indicated in cases with" exact="cirrhosis" post="associated with deteriorating hepatic synthetic function, renal function, and"/>
  <result pre="following criteria. In essence, non-urgent transplants should be postponed, and" exact="acute" post="liver failure can be done according to the standard"/>
  <result pre="criteria. In essence, non-urgent transplants should be postponed, and acute" exact="liver failure" post="can be done according to the standard indications, acute"/>
  <result pre="liver failure can be done according to the standard indications," exact="acute" post="on chronic Liver failure decisions for transplantation should be"/>
  <result pre="can be done according to the standard indications, acute on" exact="chronic" post="Liver failure decisions for transplantation should be based on"/>
  <result pre="COVID-19 pandemic [10]. As the organism is predominantly found in" exact="respiratory" post="secretions, lungs are considered high-risk organs for transmission of"/>
  <result pre="patient's condition, unfortunately, it exposes physicians to the risk of" exact="infection" post="and becomes a source of the virus spread. Therefore,"/>
  <result pre="even be more severe in transplant recipients, especially in the" exact="absence of" post="effective therapy. Financially speaking, it can be a possible"/>
  <result pre="been transplanted after getting informed consent from patients. Nevertheless, this" exact="disease" post="has a different risk profile compared to HCV. As"/>
  <result pre="so judicious decisions and strict precautions became now mandatory [40]." exact="Streptococcal" post="pneumonia and influenza vaccines are strongly recommended to all"/>
  <result pre="judicious decisions and strict precautions became now mandatory [40]. Streptococcal" exact="pneumonia" post="and influenza vaccines are strongly recommended to all recipients"/>
  <result pre="prior to LTX, together with strict prophylaxis against complications of" exact="cirrhosis" post="to reduce the number of hospital admissions [41]. It"/>
  <result pre="is also recommended to test for COVID-19 in patients with" exact="acute" post="decompensation or Acute on top of chronic liver failure"/>
  <result pre="to test for COVID-19 in patients with acute decompensation or" exact="Acute" post="on top of chronic liver failure (ACLF) [39]. For"/>
  <result pre="in patients with acute decompensation or Acute on top of" exact="chronic" post="liver failure (ACLF) [39]. For those on LTX lists,"/>
  <result pre="patients with acute decompensation or Acute on top of chronic" exact="liver failure" post="(ACLF) [39]. For those on LTX lists, it is"/>
  <result pre="totally exclude the infection. Alternatively, computed tomography (CT) of the" exact="chest" post="can be considered [42]. Pre-procedure consent should include the"/>
  <result pre="using online clinics and phone calls as a substitute to" exact="primary" post="clinics can prevent unnecessary risk of infection. Doctors may"/>
  <result pre="restricting it only to urgent ones also help to prevent" exact="nosocomial infections" post="[37]. Modifications of the outpatient transplant clinics by widening"/>
  <result pre="it only to urgent ones also help to prevent nosocomial" exact="infections" post="[37]. Modifications of the outpatient transplant clinics by widening"/>
  <result pre="clinics by widening the patientsâ€™ waiting areas and following strict" exact="infection" post="control precautions is of utmost importance [43]. Workforce affairs"/>
  <result pre="involved in postoperative care of LTX recipients. Such management includes" exact="infection" post="control with extra care directed at preventing postoperative infections,"/>
  <result pre="with extra care directed at preventing postoperative infections, including COVID-19" exact="infection" post="[40]. Liver transplant recipients should be admitted to separate"/>
  <result pre="recipients should be admitted to separate wards where there is" exact="complete" post="separation from COVID-19 admission wards, along with the strict"/>
  <result pre="in areas without significant COVID-19 community spread [45]. Hospital admission" exact="of liver" post="transplant recipients should be considered only for patients suffering"/>
  <result pre="for patients suffering from major complications like rejection, decompensation, or" exact="vascular" post="complications. During in-person outpatient follow up visits, liver transplant"/>
  <result pre="to perform his routine laboratory investigations, including drug levels at" exact="primary" post="care facilities [39]. Telemedicine can mitigate exposure of both"/>
  <result pre="critical care management to support prompt graft recovery and prevent" exact="systemic" post="complications [50]. The early postoperative period is a critical"/>
  <result pre="complications (medical and surgical) are mandatory. The Intensive care management" exact="of liver" post="transplanted patients mainly focuses on rapid hemodynamic stabilization, early"/>
  <result pre="focuses on rapid hemodynamic stabilization, early weaning from mechanical ventilation," exact="coagulopathy" post="correction, preservation of kidney function, graft rejection prevention, proper"/>
  <result pre="of kidney function, graft rejection prevention, proper fluid administration, and" exact="infection" post="prophylaxis [50]. Based on the current situation with the"/>
  <result pre="Based on the current situation with the conflict of the" exact="limited" post="capacity of ICU beds and the urgent need for"/>
  <result pre="different routes inside the ICU to decrease the risk of" exact="infection" post="[51]. Another way to minimize the possibility of ICU"/>
  <result pre="expected. Chloroquine and hydroxychloroquine Chloroquine and hydroxychloroquine act either as" exact="viral" post="entry blockers or as immunomodulators. Despite encouraging preliminary reports,"/>
  <result pre="investigational drug with antiviral activities through its selective inhibition of" exact="viral" post="RNA-dependent RNA polymerase [55]. Favipiravir increase concentration of pioglitazone,"/>
  <result pre="combination A fixed-dose combination for the prevention and treatment of" exact="HIV infection." post="The cytochrome P450 inhibitory effects of ritonavir prolong the"/>
  <result pre="role in the treatment of SARS. As it causes dose-dependent" exact="hemolytic anemia," post="Ribavirin may potentiate the hematological toxicity of Interferon-beta and"/>
  <result pre="[57]. Interferon beta One of the lessons learned from MERS-CoV" exact="infections" post="is that host inflammatory responses play a major role"/>
  <result pre="is that host inflammatory responses play a major role in" exact="disease" post="progression. This was the base of using interferon-beta in"/>
  <result pre="was the base of using interferon-beta in MERS-CoV and COVID-19" exact="infections" post="[55]. In the setting of LTX, Interferon-beta had no"/>
  <result pre="with chloroquine and hydroxychloroquine may increase its toxicity [57]. Management" exact="of liver" post="transplant patients on immune suppressive therapy to prevent the"/>
  <result pre="therapy to prevent the acquisition of COVID-19 Patients with advanced" exact="liver disease" post="and those after LTX represent vulnerable patient cohorts with"/>
  <result pre="to prevent the acquisition of COVID-19 Patients with advanced liver" exact="disease" post="and those after LTX represent vulnerable patient cohorts with"/>
  <result pre="LTX represent vulnerable patient cohorts with an increased risk of" exact="infection" post="and/or a severe course of COVID-19 Because of the"/>
  <result pre="response associated with increased serum interleukin-6 (IL-6), interleukin-8 (IL-8), and" exact="tumor" post="necrosis factor-alpha (TNF-Î±) levels may be the main driver"/>
  <result pre="necrosis factor-alpha (TNF-Î±) levels may be the main driver for" exact="pulmonary" post="injury due to COVID-19, immunosuppression may be protective [33],"/>
  <result pre="[33], [60]. Coronaviruses have not shown to cause more severe" exact="disease" post="in immunosuppressed patients. More interestingly, reviewing the mortality and"/>
  <result pre="years old) male sex and presence of comorbidities (obesity, diabetes," exact="heart" post="disease, lung disease, kidney disease) [10]. Available data on"/>
  <result pre="male sex and presence of comorbidities (obesity, diabetes, heart disease," exact="lung disease," post="kidney disease) [10]. Available data on coronavirus before and"/>
  <result pre="that immunosuppressed patients are not at increased risk of severe" exact="pulmonary" post="disease compared to the general population; however, immunosuppression may"/>
  <result pre="immunosuppressed patients are not at increased risk of severe pulmonary" exact="disease" post="compared to the general population; however, immunosuppression may prolong"/>
  <result pre="disease compared to the general population; however, immunosuppression may prolong" exact="viral" post="shedding in post-transplant patients with COVID-19 if they are"/>
  <result pre="[36], [60]. Immunosuppressive therapy should be started in patients with" exact="liver disease" post="with or without COVID-19 who have strong indications for"/>
  <result pre="[60]. Immunosuppressive therapy should be started in patients with liver" exact="disease" post="with or without COVID-19 who have strong indications for"/>
  <result pre="or without COVID-19 who have strong indications for treatment (e.g.," exact="autoimmune hepatitis," post="liver transplant patients, and in cases of graft rejection)."/>
  <result pre="reducing the dosage or stopping immunosuppressants as this may precipitate" exact="acute" post="rejection in a liver transplant recipient, so there is"/>
  <result pre="for the prevention of progression of mild COVID-19 to severe" exact="pneumonia" post="is unknown. WHO recommends avoiding corticosteroids for the treatment"/>
  <result pre="the dosage of prednisone, maintaining a sufficient dosage to avoid" exact="adrenal insufficiency" post="[39]. Similarly, it is also advised to reduce daily"/>
  <result pre="Azathioprine especially in the setting of lymphopenia, fever, or worsening" exact="pneumonia" post="attributed to COVID-19. In the case of ground-glass opacities,"/>
  <result pre="pneumonia attributed to COVID-19. In the case of ground-glass opacities," exact="pneumonia" post="switching mammalian target of rapamycin (mTOR) to calcineurin inhibitors"/>
  <result pre="can be maintained [59]. References References 1World Health Organization. â€œCoronavirus" exact="disease" post="2019â€�. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed April 14, 2020. 2World Health Organization."/>
  <result pre="cases with COVID-19. https://www.medrxiv.org/content/10.1101/2020.02.26.20028191v1 accessed on April 13, 2020. 12SchÃ¼tteA.CiesekS.WedemeyerH.Influenza" exact="virus infection" post="as precipitating event of acute-on-chronic liver failureJ Hepatol70201979779930635243 13MichaelsM.G.La"/>
  <result pre="with COVID-19. https://www.medrxiv.org/content/10.1101/2020.02.26.20028191v1 accessed on April 13, 2020. 12SchÃ¼tteA.CiesekS.WedemeyerH.Influenza virus" exact="infection" post="as precipitating event of acute-on-chronic liver failureJ Hepatol70201979779930635243 13MichaelsM.G.La"/>
  <result pre="as precipitating event of acute-on-chronic liver failureJ Hepatol70201979779930635243 13MichaelsM.G.La HozR.M.Danziger-IsakovL.BlumbergE.A.KumarD.GreenM.Coronavirus" exact="disease" post="2019: Implications of emerging infections for transplantationAm J Transplant202010.1111/ajt.15832"/>
  <result pre="liver failureJ Hepatol70201979779930635243 13MichaelsM.G.La HozR.M.Danziger-IsakovL.BlumbergE.A.KumarD.GreenM.Coronavirus disease 2019: Implications of emerging" exact="infections" post="for transplantationAm J Transplant202010.1111/ajt.15832 14AlGhamdiM.MushtaqF.AwnN.ShalhoubS.MERS CoV infection in two"/>
  <result pre="Implications of emerging infections for transplantationAm J Transplant202010.1111/ajt.15832 14AlGhamdiM.MushtaqF.AwnN.ShalhoubS.MERS CoV" exact="infection" post="in two renal transplant recipients: case reportAm J Transplant1520151101110425716741"/>
  <result pre="Health Organization: Rational use of personal protective equipment for coronavirus" exact="disease" post="2019 (COVID-19). Interim guidance. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/infection-prevention-and-control. Accessed April"/>
  <result pre="for liver transplantation in adults: 2013 practice guideline by the" exact="American" post="Association for the Study of Liver Diseases and the"/>
  <result pre="practice guideline by the American Association for the Study of" exact="Liver Diseases" post="and the American Society of TransplantationHepatology5920141144116524716201 20LeeW.M.StravitzR.T.LarsonA.M.Introduction to the"/>
  <result pre="guideline by the American Association for the Study of Liver" exact="Diseases" post="and the American Society of TransplantationHepatology5920141144116524716201 20LeeW.M.StravitzR.T.LarsonA.M.Introduction to the"/>
  <result pre="American Association for the Study of Liver Diseases and the" exact="American" post="Society of TransplantationHepatology5920141144116524716201 20LeeW.M.StravitzR.T.LarsonA.M.Introduction to the revised American Association"/>
  <result pre="and the American Society of TransplantationHepatology5920141144116524716201 20LeeW.M.StravitzR.T.LarsonA.M.Introduction to the revised" exact="American" post="Association for the Study of Liver Diseases position paper"/>
  <result pre="20LeeW.M.StravitzR.T.LarsonA.M.Introduction to the revised American Association for the Study of" exact="Liver Diseases" post="position paper on acute liver failure 2011Hepatology55201296596710.1002/hep.2555122213561 21LeeW.M.Acute liver"/>
  <result pre="to the revised American Association for the Study of Liver" exact="Diseases" post="position paper on acute liver failure 2011Hepatology55201296596710.1002/hep.2555122213561 21LeeW.M.Acute liver"/>
  <result pre="Association for the Study of Liver Diseases position paper on" exact="acute" post="liver failure 2011Hepatology55201296596710.1002/hep.2555122213561 21LeeW.M.Acute liver failureSemin Respir Crit Care"/>
  <result pre="for the Study of Liver Diseases position paper on acute" exact="liver failure" post="2011Hepatology55201296596710.1002/hep.2555122213561 21LeeW.M.Acute liver failureSemin Respir Crit Care Med332012364522447259 22OstapowiczG.FontanaR.J.SchiÃ¸dtF.V.Results"/>
  <result pre="Respir Crit Care Med332012364522447259 22OstapowiczG.FontanaR.J.SchiÃ¸dtF.V.Results of a prospective study of" exact="acute" post="liver failure at 17 tertiary care centers in the"/>
  <result pre="Crit Care Med332012364522447259 22OstapowiczG.FontanaR.J.SchiÃ¸dtF.V.Results of a prospective study of acute" exact="liver failure" post="at 17 tertiary care centers in the United StatesAnn"/>
  <result pre="the United StatesAnn Intern Med137200294795412484709 23Oâ€™LearyJ.G.LepeR.DavisG.L.Indications for liver transplantationGastroenterology13420081764177618471553 24YuL.IoannouG.N.Survival" exact="of liver" post="transplant recipients with hemochromatosis in the United StatesGastroenterology133200748949517681170 25SilvermanE.K.SandhausR.A.Clinical"/>
  <result pre="23Oâ€™LearyJ.G.LepeR.DavisG.L.Indications for liver transplantationGastroenterology13420081764177618471553 24YuL.IoannouG.N.Survival of liver transplant recipients with" exact="hemochromatosis" post="in the United StatesGastroenterology133200748949517681170 25SilvermanE.K.SandhausR.A.Clinical practice. Alpha1-antitrypsin deficiencyN Engl"/>
  <result pre="treatment of nonalcoholic steatohepatitisN Engl J Med37720172063207229166236 28CharltonM.R.BurnsJ.M.PedersenR.A.WattK.D.HeimbachJ.K.DierkhisingR.A.Frequency and outcomes" exact="of liver" post="transplantation for nonalcoholic steatohepatitis in the United StatesGastroenterology14120111249125321726509 29IqbalS.SmithK.A.KhungarV.Hepatopulmonary"/>
  <result pre="liver transplantation for nonalcoholic steatohepatitis in the United StatesGastroenterology14120111249125321726509 29IqbalS.SmithK.A.KhungarV.Hepatopulmonary" exact="syndrome" post="and portopulmonary hypertension: implications for liver transplantationClin Chest Med38201778579529128026"/>
  <result pre="and portopulmonary hypertension: implications for liver transplantationClin Chest Med38201778579529128026 30CosardereliogluC.CosarA.M.GurakarM.Portopulmonary" exact="hypertension" post="and liver transplant: recent review of the literatureExp Clin"/>
  <result pre="with 2019 novel coronavirus in Wuhan, ChinaLancet (London, England)395102232020497506 34KumarD.HumarA.Emerging" exact="viral" post="infections in transplant recipientsCurr Opin Infect Diseases184200533743415985831 35El-MeteiniM.FayezA.FathyM.Living related"/>
  <result pre="2019 novel coronavirus in Wuhan, ChinaLancet (London, England)395102232020497506 34KumarD.HumarA.Emerging viral" exact="infections" post="in transplant recipientsCurr Opin Infect Diseases184200533743415985831 35El-MeteiniM.FayezA.FathyM.Living related liver"/>
  <result pre="and Transplantation Town Hall (Donor Issues and Candidate Concerns) [Online]:" exact="American" post="society of Transplantion 2020 12-4-2020. Podcast. Available from: https://www.youtube.com/watch?reload=9&amp;amp;v=0xaFpTba0T8&amp;amp;t="/>
  <result pre="from: https://www.youtube.com/watch?reload=9&amp;amp;v=0xaFpTba0T8&amp;amp;t= accessed April 13, 2020 39BoettlerT.NewsomeP.N.MondelliM.U.Care of patients with" exact="liver disease" post="during the COVID-19 pandemic: EASL-ESCMID position paperJHEP Rep202010.1016/j.jhepr.2020.100113 40KumarD.ManuelO.NatoriY.EgawaH.GrossiP.HanS.-H.Fernandezâ€�RuizM.HumarA.COVIDâ€�19:"/>
  <result pre="https://www.youtube.com/watch?reload=9&amp;amp;v=0xaFpTba0T8&amp;amp;t= accessed April 13, 2020 39BoettlerT.NewsomeP.N.MondelliM.U.Care of patients with liver" exact="disease" post="during the COVID-19 pandemic: EASL-ESCMID position paperJHEP Rep202010.1016/j.jhepr.2020.100113 40KumarD.ManuelO.NatoriY.EgawaH.GrossiP.HanS.-H.Fernandezâ€�RuizM.HumarA.COVIDâ€�19:"/>
  <result pre="perspective on successfully navigating a pandemicAm J Transplant202010.1111/ajt.15876 41FagiuoliS.ColliA.BrunoR.Management of" exact="infections" post="pre- and post-liver transplantation: Report of an AISF consensus"/>
  <result pre="Clin Microbiol202010.1128/JCM.00297-20 43WuZ.McGooganJ.M.Characteristics of and important lessons from the coronavirus" exact="disease" post="2019 (COVID-19) outbreak in ChinaJAMA2020[Internet] available from : https://jamanetwork.com/journals/jama/fullarticle/2762130external"/>
  <result pre="https://jamanetwork.com/journals/jama/fullarticle/2762130external accessed on April 13, 2020 44World Health Organization. Coronavirus" exact="disease" post="(COVID-19) outbreak: rights, roles and responsibilities of health workers,"/>
  <result pre="critical care response to a hospital outbreak of Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) infection: an observational studyAnn Intensive Care61201610110.1186/s13613-016-0203-z27778310"/>
  <result pre="care response to a hospital outbreak of Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) infection: an observational studyAnn Intensive Care61201610110.1186/s13613-016-0203-z27778310 50FeltraccoP.BarbieriS.GalligioniH.MichielettoE.CarolloC.OriC.Intensive"/>
  <result pre="(MERS-CoV) infection: an observational studyAnn Intensive Care61201610110.1186/s13613-016-0203-z27778310 50FeltraccoP.BarbieriS.GalligioniH.MichielettoE.CarolloC.OriC.Intensive care management" exact="of liver" post="transplanted patientsWorld J Hepatol332011617110.4254/wjh.v3.i3.6121487537 51CardosoF.S.Liver transplantation in an ICU"/>
  <result pre="Drug Interactions. https://www.covid19-druginteractions.org accessed April 13, 2020. 58BinL.YangzhongW.YuanyuanZ.HuiboS.FanjunZ.ZhishuiC.Successful Treatment of" exact="Severe" post="COVID-19 Pneumonia in a Liver Transplant Recipient [published online"/>
  <result pre="https://www.covid19-druginteractions.org accessed April 13, 2020. 58BinL.YangzhongW.YuanyuanZ.HuiboS.FanjunZ.ZhishuiC.Successful Treatment of Severe COVID-19" exact="Pneumonia" post="in a Liver Transplant Recipient [published online ahead of"/>
  <result pre="online ahead of print, 2020 Apr 3]Am J Transplant202010.1111/ajt.15901 59Massachusetts" exact="General" post="Hospital COVID-19 Treatment Guidance. https://www.massgeneral.org/news/coronavirus/treatment-guidance accessed April, 13, 2020."/>
  <result pre="print, 2020 Mar 20]. Liver Transpl. 2020;10.1002/lt.25756. doi:10.1002/lt.25756. 61HuiD.S.AzharE.I.KimY.J.MemishZ.A.OhM.D.ZumlaA.Middle East" exact="respiratory" post="syndrome coronavirus: risk factors and determinants of primary, household,"/>
  <result pre="2020 Mar 20]. Liver Transpl. 2020;10.1002/lt.25756. doi:10.1002/lt.25756. 61HuiD.S.AzharE.I.KimY.J.MemishZ.A.OhM.D.ZumlaA.Middle East respiratory" exact="syndrome" post="coronavirus: risk factors and determinants of primary, household, and"/>
  <result pre="household, and nosocomial transmissionLancet Infect Dis1882018e217e22710.1016/S1473-3099(18)30127-029680581 62ZhuL.XuX.MaK.Successful recovery of COVID-19" exact="pneumonia" post="in a renal transplant recipient with long-term immunosuppression [published"/>
  <result pre="17]Am J Transplant202010.1111/ajt.15869 63World Health Organization. Clinical management of severe" exact="acute" post="respiratory infection (SARI) when COVID-19 disease is suspected: Interim"/>
  <result pre="J Transplant202010.1111/ajt.15869 63World Health Organization. Clinical management of severe acute" exact="respiratory" post="infection (SARI) when COVID-19 disease is suspected: Interim guidance."/>
  <result pre="Transplant202010.1111/ajt.15869 63World Health Organization. Clinical management of severe acute respiratory" exact="infection" post="(SARI) when COVID-19 disease is suspected: Interim guidance. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"/>
  <result pre="Clinical management of severe acute respiratory infection (SARI) when COVID-19" exact="disease" post="is suspected: Interim guidance. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected Accessed online April 13,"/>
 </snippets>
</snippetsTree>
